Long-term efficacy and safety of aerosolized tobramycin 300 mg/4 ml in cystic fibrosis

Abstract

Overall, TNS4 demonstrated short-term clinical benefits similar to TNS5 which were maintained during the long-term use of TNS4 and was also associated with a favorable tolerability profile.